Aardvark Therapeutics (AARD)

Profile

Full Name

Aardvark Therapeutics, Inc. Common Stock

Ticker Symbol

AARD

Exchange

NASDAQ

Country

United States

IPO

Indexes

Not included

Employees

17

Key Details

Price

$7.14(+1.71%)

Market cap

$154.91M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.96(-72.42% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 10, 25 RBC Capital
Outperform
Mar 10, 25 Morgan Stanley
Overweight
Mar 10, 25 Cantor Fitzgerald
Overweight
Mar 10, 25 B of A Securities
Buy

Institutional Ownership

  • What is the ticker symbol for Aardvark Therapeutics?
  • Does Aardvark Therapeutics pay dividends?
  • What sector is Aardvark Therapeutics in?
  • What industry is Aardvark Therapeutics in?
  • What country is Aardvark Therapeutics based in?
  • Is Aardvark Therapeutics in the S&P 500?
  • Is Aardvark Therapeutics in the NASDAQ 100?
  • Is Aardvark Therapeutics in the Dow Jones?
  • When was Aardvark Therapeutics's last earnings report?
  • When does Aardvark Therapeutics report earnings?
  • Should I buy Aardvark Therapeutics stock now?

What is the ticker symbol for Aardvark Therapeutics?

The ticker symbol for Aardvark Therapeutics is NASDAQ:AARD

Does Aardvark Therapeutics pay dividends?

No, Aardvark Therapeutics does not pay dividends

What sector is Aardvark Therapeutics in?

Aardvark Therapeutics is in the Healthcare sector

What industry is Aardvark Therapeutics in?

Aardvark Therapeutics is in the Biotechnology industry

What country is Aardvark Therapeutics based in?

Aardvark Therapeutics is headquartered in United States

Is Aardvark Therapeutics in the S&P 500?

No, Aardvark Therapeutics is not included in the S&P 500 index

Is Aardvark Therapeutics in the NASDAQ 100?

No, Aardvark Therapeutics is not included in the NASDAQ 100 index

Is Aardvark Therapeutics in the Dow Jones?

No, Aardvark Therapeutics is not included in the Dow Jones index

When was Aardvark Therapeutics's last earnings report?

Aardvark Therapeutics's most recent earnings report was on Mar 31, 2025

When does Aardvark Therapeutics report earnings?

The next expected earnings date for Aardvark Therapeutics is May 30, 2025

Should I buy Aardvark Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page